In addition, a wide scope of signaling pathways have been characterized to modulate the consequence of insulin‐triggered AKT activation through directly regulating AKT or indirectly affecting AKT upstream and downstream branches, thereby influencing the progression of IR and T2DM (Figure 5). The gene discussed is AKT1; the disease is type 2 diabetes mellitus.